mail
versión imprimible
 
 

4th iPSC Drug Development and Manufacturing Summit

Evvnt Promotion / evvnt
Archivo
-
01.10.2024 - 03.10.2024  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 08:00 - 17:00
 
Temas de la conferencia
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2453698-3?pid=4832

Speakers: Allen Feng, Founder & Chief Scientific Officer, HebeCell, Anne Plant, Fellow Chief, Biosystems and Biomaterials Division, National Institute of Standards & Technology (NIST), and more
 

Información e inscripción:

https://go.evvnt.com/2453698-2?pid=4832
Ms. Lara Chick
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Hilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Health Forum GasteinÖsterreichische Akademie der ÄrzteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAnästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteÄrzte der Welt